Netherlands· NL-11d0775e881c
ARTISS, oplossingen voor weefsellijm
A lokale hämostatika, kombinationen product containing aprotinine (synthetisch) + calciumchloride 2-water (e 509) + fibrinogeen, humaan + thrombine, humaan, registered in Netherlands by Baxter B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lokale hämostatika, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Lokale hämostatika, kombinationen · ATC B02BC30
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- APROTININE (SYNTHETISCH) + CALCIUMCHLORIDE 2-WATER (E 509) + FIBRINOGEEN, HUMAAN + THROMBINE, HUMAAN
- Manufacturer
- Baxter B.V.
- Country
- Netherlands (NL)
- ATC code
- B02BC30
- ATC class
- Lokale Hämostatika, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id100631
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BC30
Lokale hämostatika, kombinationen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db670fa2-c8d8-4b6c-bdb3-8c20a505fc6e GET /v1/drugs/db670fa2-c8d8-4b6c-bdb3-8c20a505fc6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Weefsellijm",
"route": "Epilesionaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100631_smpc.pdf",
"strength": null,
"atc_label": "Combinations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100631",
"excipients": [
"HISTIDINE, (L-)",
"HUMAAN ALBUMINE",
"HUMAAN ALBUMINE",
"NATRIUMCHLORIDE",
"NICOTINAMIDE",
"POLYSORBAAT 80 (E 433)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE",
"WATER VOOR INJECTIE"
],
"substances": [
"APROTININE (SYNTHETISCH)",
"CALCIUMCHLORIDE 2-WATER (E 509)",
"FIBRINOGEEN, HUMAAN",
"THROMBINE, HUMAAN"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100631.pdf",
"authorised_at": "2010/06/17",
"procedure_number": "AT/H/0186/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "100631",
"additional_monitoring": "N"
}See everything about lokale hämostatika, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.